Martine Dehlinger-Kremer

WORK HISTORY

EDUCATION

SKILLS

ABOUT MARTINE DEHLINGER-KREMER

I hold a PhD in Sciences from J.W. Goethe University in Francfort, a Diploma of Advanced Study in Neurophysiology from Université Louis Pasteur in Strasbourg, and a Master of Sciences from Université Moulin de la Housse in Reims.I am a committed advocate for children and special patient populations, with more than 30 years of experience in global drug development, regulatory strategy and pediatric research. Throughout my career, I have been driven by a clear and consistent goal: to ensure that safe and effective treatments are accessible to every child, everywhere, for every condition.In December 2025, I joined UCB Biosciences as Senior Development Strategy Lead Pediatrics within the Department of Special Patient Populations. In this role, I advise and support the implementation of cross-functional development strategies to accelerate global access to innovative therapies for children.Beyond UCB, I remain actively engaged in advancing pediatric drug development internationally. I co-chair the European Forum for Good Clinical Practice (EFGCP) Children’s Medicines Working Party, serve on both the EFGCP Board and the International Children’s Advisory Network (iCAN) Board, and am a member of the EFPIA Pediatric Working Group as well as the PhRMA Pediatric Working Group. I also contribute to the TOPRA Pediatrics Special Interest Network, and support patient-centric, harmonized regulatory approaches through ACT EU and Enpr-EMA initiatives.My work has been recognized internationally, including being named one of PharmaVOICE’s 100 Most Inspiring People in Life Sciences and receiving the TOPRA Award for Regulatory Excellence in 2025. I firmly believe that the future of pediatric drug development lies in innovation, collaboration and empathy. Together, we can ensure that children are never left behind in the progress of science.